Ghent, Belgium, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announces the upcoming participation of the company in a variety of European investor and business events. Biotalys welcomes the opportunity to engage with institutional and retail investors during these events to share the company’s exciting development since its IPO in July 2021.
Berenberg Food Ingredients & Chemicals Conference 2022
September 13-14, 2022
London, UK
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
Kepler Cheuvreux Autumn Conference
September 15, 2022
Paris, France
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
World Agri-Tech Innovation Summit
September 20-21, 2022
London, UK
Panel debate with Patrice Sellès, CEO of Biotalys
L’investisseur on Tour
September 26, 2022
Braine-L'Alleud, Belgium or via livestream
Presentation by Patrice Sellès (event in French)
KBC Securities Sustainability Conference
September 29, 2022
Virtual
Group presentation by Biotalys’ management and 1-2-1 meetings with investors
Annual Biocontrol Industry Meeting (ABIM)
October 24-26, 2022
Basel, Switzerland
Participation by Biotalys’ management
FoodTech Congress
October 27, 2022
Virtual
Keynote speech by Patrice Sellès
VFB Soirée
October 27, 2022
Webinar organized by the Flemish Retail Investor Association (VFB) with Patrice Sellès
About Biotalys
Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
For further information, please contact
Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com
Important Notice
This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ‘aim’, 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.
